<DOC>
	<DOCNO>NCT00516945</DOCNO>
	<brief_summary>Patients non-lymphoma non-leukaemia cancer also hepatitis B carrier risk hepatitis B reactivation chemotherapy . Lamivudine use effectively control hepatitis upon reactivation chemotherapy chemotherapy may need interrupt . The study aim investigate whether add anti-viral drug Lamivudine start chemotherapy patient , rather time hepatitis reactivation reactivation , help improve delivery chemotherapy patient .</brief_summary>
	<brief_title>A Study Investigate Whether Immediate Use Deferred Use Anti-viral Drug Lamivudine Will Help Better Safe-guard Delivery Chemotherapy Patients With Cancer Who Are Also Hepatitis B Carriers</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>1 . Patient histologyproven malignant solid tumor malignant lymphoma 2 . Patients age 18 75 3 . Patients Karnofsky performance score ( KPS ) least 60 4 . Patients plan least 4 cycle intensive cytotoxic chemotherapy ( either part curative therapy palliative therapy ) , except receive single agent cisplatin chemotherapy alone concurrently radiation radiosensitization 5 . Patients least 6 month ' life expectany date recruitment 6 . Patients normal liver function test include alanine aminpotransferase ( ALT ) , alkaline phosphatase ( ALP ) , gamma glutamyltranspeptidase ( GGT ) , bilirubin 7 . Patients known history radiological &amp; /or histological diagnosis chronic active hepatitis cirrhosis cuase , history prior hepatitis B reactivation , prior chronic therapy HBV within 6 month 8 . Patients evidence autoimmune hepatitis , hepatitis C delta virus infection , HIV infection radiological evidence liver metastasis 9 . Patients negative pregnancy test female gender childbearing age 1 . Patients age &lt; 18 &gt; 75 2 . Patients Karnofsky performance score ( KPS ) &lt; 60 3 . Patients plan single agent cisplatin chemotherapy alone concurrently radiation radiosensitization 4 . Patients &lt; 6 month ' life expectancy date recruitment 5 . Patients abnormal liver function test include alanine aminotransferase ( ALT ) , alkaline phosphatase ( ALP ) , gamma glutamyl transpeptidase ( GGT ) , bilirubin 6 . Patients known history radiological and/or histological diagnosis chronic active hepatitis cirrhosis cause , history prior hepatitis B reactivation , prior chronic therapy HBV within 6 month 7 . Patients autoimmune hepatitis , hepatitis C delta virus infection , HIV infection radiological evidence liver metastasis 8. pregnant female patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>hepatitis B cancer chemotherapy</keyword>
</DOC>